To discuss the rare familial transmission of invasive Group A Streptococcus (GAS) infection and its clinical manifestations.
Approach:
Case Reports: The article presents two case reports of related patients with invasive GAS infections, detailing their hospital courses, treatments, and outcomes.
Key Findings:
The incidence of invasive GAS infections has risen from 3.8 cases per 100,000 individuals (2005-2012) to 8.2 per 100,000 in 2022.
Invasive GAS infections can manifest as cellulitis, pneumonia, and other severe conditions, as seen in the two case reports.
One patient developed septic shock, while the other presented with pneumonia and respiratory distress.
Interpretation:
The case series discusses familial transmission of invasive GAS infections and highlights the varied clinical presentations observed in the two patients.
Limitations:
The case series is limited by the small number of patients reported, which may not represent the broader population.
Further research is needed to understand the mechanisms of familial transmission and the rising incidence of invasive GAS infections.
Conclusion:
The findings highlight the importance of recognizing invasive GAS infections and the potential for familial transmission.
Biomarker-guided patient selection may help identify patients with sepsis who could benefit from endotoxin-targeted therapy, although confirmatory evidence is still needed.